Back to top

MiMedx price target raised to $7 from $5 at Lake Street

Lake Street analyst Brooks O’Neil raised the firm’s price target on MiMedx (MDXG) to $7 from $5 and keeps a Buy rating on the shares after the comp...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Sanara MedTech Inc. (SMTI)